Results 191 to 200 of about 1,772,484 (313)

Resurgence of Ebola in Uganda: Response Strategies, Lessons Learned, and Future Directions

Health Science Reports, Volume 8, Issue 7, July 2025.
ABSTRACT Introduction The recent resurgence of Ebola virus disease (EVD), specifically the Sudan virus strain, in Uganda highlights the ongoing threat of emerging infectious diseases. This article aims to analyze the multifaceted factors contributing to this resurgence, evaluate the public health impact, and assess the effectiveness of response ...
Majani Edward, Sylivester Muhigi, Joan Mundua, Ally Ally   +3 more
wiley   +1 more source

Comparison of cellular gene expression in Ebola-Zaire and Ebola-Reston virus-infected primary human monocytes [PDF]

, 1999
Charlie Xiang, Howard A. Young, Harold Alterson, David M. Reynolds, M. Bittner, Yaning Chen, Gerald Gooden, Yuan Jiang, P Meltzer, J. Trent, Judy A. Mikovits, Kevin Anderson   +11 more
openalex   +1 more source

In Vitro Synergistic Antiviral Effects of β‐D‐N4‐hydroxycytidine and Teriflunomide in Combination against a Broad Range of RNA Viruses

Journal of Medical Virology, Volume 97, Issue 7, July 2025.
ABSTRACT Emerging and important endemic viral diseases without effective antiviral are important public health threat. An effective broad‐spectrum antiviral can be a pivotal tool to mitigate future epidemics and provide a solution for endemic viral diseases. Molnupiravir, a pyrimidine analog, is known for the COVID‐19 treatment.
Thanyaporn Sirihongthong, Kunlakanya Jitobaom, Chompunuch Boonarkart, Songkran Thongon, Prasert Auewarakul   +4 more
wiley   +1 more source

Gleanings from the Harvest: Suggestions for Priority Actions against Ebola Virus Epidemics [PDF]

, 1999
Karl M. Johnson
openalex   +1 more source

Human Alveolar Macrophages Detect SARS‐CoV‐2 Envelope Protein Through TLR2 and TLR4 and Secrete Cytokines in Response

Immunology, Volume 175, Issue 3, Page 391-401, July 2025.
Alveolar macrophages (AMs)—the most numerous immune cells of the lung—respond to viral infections by secreting cytokines to summon other immune cells. We investigated whether AMs recognize SARS‐CoV‐2 proteins and how they respond. AMs did not sense spike protein but did recognize envelope protein via the pattern recognition receptors TLR2 and TLR4 ...
Conor Grant, Emily Duffin, Finbarr O’Connell, Parthiban Nadarajan, Colm Bergin, Joseph Keane, Mary P. O'Sullivan   +6 more
wiley   +1 more source

Ebola virus disease 2014 [PDF]

, 2014
Ebola virus disease was irst described in 1976 originating from the Ebola River in the Democratic Republic of Congo. Since then, Ebola virus has become an important public health threat in Africa, and now it is of great concern worldwide due to the ...
Arellanos Soto, Daniel, Bravo de la Cruz, Verónica, Galán Huerta, Kame Alberto, Ramos Jiménez, Javier, Rivas Estilla, Ana María   +4 more
core  

Distinct Mechanisms of Entry by Envelope Glycoproteins of Marburg and Ebola (Zaire) Viruses [PDF]

, 2000
Stephen Chan, Roberto F. Speck, C. Melissa, Mark A. Goldsmith   +3 more
openalex   +1 more source

Optimising our response to a potential H5N1 avian influenza pandemic: preparing to protect people working at the human–animal interface

Medical Journal of Australia, EarlyView.
Kerrie Wiley, Catherine King, Holly Seale, Chris Degeling   +3 more
wiley   +1 more source

Marburg and Ebola Virus Infections: A Guide for their Diagnosis, Management, and Control

, 1978
N. R. Grist
openalex   +1 more source

Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses [PDF]

, 2000
Thomas W. Geisbert, Lisa E. Hensley, Tammy R. Gibb, Keith E. Steele, Nancy K. Jaax, Peter B. Jahrling   +5 more
openalex   +1 more source